Caribou Biosciences, Inc.
CRBU
$1.86
$0.105.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.60% | -23.01% | -3.13% | -41.62% | -91.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.60% | -23.01% | -3.13% | -41.62% | -91.45% |
| Cost of Revenue | -26.01% | -34.90% | 7.79% | -4.52% | -94.27% |
| Gross Profit | 155.44% | -6.87% | -24.88% | -0.24% | 107.84% |
| SG&A Expenses | -6.54% | -9.42% | -33.52% | 7.89% | 1.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.52% | -18.89% | -6.54% | -1.58% | 5.14% |
| Operating Income | 23.11% | 18.56% | 6.71% | -2.22% | -161.31% |
| Income Before Tax | 20.57% | -43.51% | 3.01% | -3.46% | -246.77% |
| Income Tax Expenses | -- | -- | -- | -104.66% | -- |
| Earnings from Continuing Operations | 20.57% | -43.51% | 3.01% | -2.85% | -246.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.57% | -43.51% | 3.01% | -2.85% | -246.77% |
| EBIT | 23.11% | 18.56% | 6.71% | -2.22% | -161.31% |
| EBITDA | 22.37% | 19.66% | 7.82% | -1.06% | -183.91% |
| EPS Basic | 22.98% | -39.35% | 6.54% | 0.23% | -221.11% |
| Normalized Basic EPS | 22.95% | -8.05% | 6.55% | 0.99% | -221.18% |
| EPS Diluted | 22.98% | -39.35% | 6.54% | 0.23% | -221.11% |
| Normalized Diluted EPS | 22.95% | -8.05% | 6.55% | 0.99% | -221.18% |
| Average Basic Shares Outstanding | 3.14% | 2.98% | 3.78% | 3.09% | 7.96% |
| Average Diluted Shares Outstanding | 3.14% | 2.98% | 3.78% | 3.09% | 7.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |